Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China

Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China

Source: 
Fierce Pharma
snippet: 

Merck KGaA’s North American life science division, MilliporeSigma, has made U.S. legal history thanks to its swift and voluntary efforts to expose a multimillion-dollar scheme to divert biochemical products to China.